Renaissance Technologies’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
2,013,593
+451,600
| +29% | +$2.59M | 0.02% | 982 |
|
|
2025
Q1 | $12.7M | Sell |
1,561,993
-546,623
| -26% | -$4.46M | 0.02% | 877 |
|
|
2024
Q4 | $19.9M | Buy |
2,108,616
+1,339,316
| +174% | +$12.6M | 0.03% | 672 |
|
|
2024
Q3 | $8.22M | Buy |
769,300
+137,276
| +22% | +$1.47M | 0.01% | 1144 |
|
|
2024
Q2 | $6.27M | Sell |
632,024
-324,176
| -34% | -$3.22M | 0.01% | 1172 |
|
|
2024
Q1 | $11.3M | Buy |
956,200
+878,800
| +1,135% | +$10.4M | 0.02% | 929 |
|
|
2023
Q4 | $1.1M | Sell |
77,400
-71,000
| -48% | -$1.01M | ﹤0.01% | 2348 |
|
|
2023
Q3 | $1.81M | Buy |
+148,400
| New | +$1.81M | ﹤0.01% | 1930 |
|
|
2023
Q2 | – | Sell |
-389,000
| Closed | -$4.31M | – | 4040 |
|
|
2023
Q1 | $4.31M | Buy |
+389,000
| New | +$4.31M | 0.01% | 1561 |
|
|
2022
Q4 | – | Sell |
-284,800
| Closed | -$2.97M | – | 4196 |
|
|
2022
Q3 | $2.97M | Buy |
+284,800
| New | +$2.97M | ﹤0.01% | 1764 |
|
|
2020
Q1 | – | Sell |
-129,854
| Closed | -$1.27M | – | 3545 |
|
|
2019
Q4 | $1.27M | Sell |
129,854
-1,340,946
| -91% | -$13.1M | ﹤0.01% | 2524 |
|
|
2019
Q3 | $11.8M | Buy |
1,470,800
+1,217,000
| +480% | +$9.76M | 0.01% | 1284 |
|
|
2019
Q2 | $3.17M | Buy |
+253,800
| New | +$3.17M | ﹤0.01% | 2092 |
|
|
2016
Q4 | – | Sell |
-196,400
| Closed | -$1.45M | – | 3311 |
|
|
2016
Q3 | $1.45M | Buy |
+196,400
| New | +$1.45M | ﹤0.01% | 2385 |
|
|
2015
Q1 | – | Sell |
-508,700
| Closed | -$4.23M | – | 3225 |
|
|
2014
Q4 | $4.23M | Buy |
508,700
+378,300
| +290% | +$3.15M | 0.01% | 1369 |
|
|
2014
Q3 | $776K | Buy |
+130,400
| New | +$776K | ﹤0.01% | 2145 |
|
|
2014
Q2 | – | Sell |
-121,000
| Closed | -$250K | – | 2839 |
|
|
2014
Q1 | $250K | Sell |
121,000
-278,401
| -70% | -$575K | ﹤0.01% | 2565 |
|
|
2013
Q4 | $939K | Buy |
399,401
+96,801
| +32% | +$228K | ﹤0.01% | 2105 |
|
|
2013
Q3 | $702K | Buy |
302,600
+128,956
| +74% | +$299K | ﹤0.01% | 2173 |
|
|
2013
Q2 | $405K | Buy |
+173,644
| New | +$405K | ﹤0.01% | 2310 |
|